Wearable hip-robot training to improve walking after major lower-leg burns

The Effect of Mobile Robot Assisted Gait Training on Gait Performance in Chronic Patients With Impaired Gait Function After Burn Injury : Pilot Study

Not applicable Interventional Hangang Sacred Heart Hospital · NCT07277166

This 12-week program will try using a wearable hip-assist robot during daily physiotherapy to help adults who still have walking problems six months after large lower-extremity burns walk better.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment20 (estimated)
Ages19 Years to 65 Years
SexAll
SponsorHangang Sacred Heart Hospital Academic / other
Locations1 site (Seoul)
Trial IDNCT07277166 on ClinicalTrials.gov

What this trial studies

This interventional program enrolls adults with chronic gait impairment following extensive lower-extremity burns or split-thickness skin grafting and a Functional Ambulation Category (FAC) score of 3 or higher. Participants receive one-to-one physiotherapy with a wearable hip-centered robotic device for 1 hour a day, five days a week, over 12 weeks. Outcomes are measured before and immediately after the training using FAC, the 6-Minute Walk Test, a visual analogue pain scale, spatiotemporal gait parameters (speed, cadence, step length), and sagittal joint kinematics for hip, knee, and ankle. Key exclusions include fourth-degree burns, severe communication impairments, cardiac/circulatory conditions, extreme height or BMI preventing robot fit, and high fall risk.

Who should consider this trial

Good fit: Adults over 18 with persistent gait dysfunction at least six months after split-thickness grafting or burns covering more than half of the lower extremities, with FAC score ≥3 and who fit the wearable robot (height and BMI limits) are ideal candidates.

Not a fit: Patients with fourth-degree burns affecting deep tissues, severe cognitive or communication disorders, cardiac/circulatory conditions, extreme height or obesity that prevent robot use, or a recent high fall risk are unlikely to benefit from this intervention.

Why it matters

Potential benefit: If successful, this approach could improve walking speed, endurance, posture, and independence for people with long-lasting gait problems after major lower-extremity burns.

How similar studies have performed: Wearable hip-assist robots have shown improved energy efficiency and posture in other walking populations, but their specific use for post-burn gait dysfunction is relatively novel with limited direct evidence.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* chronic patients who underwent split-thickness skin grafting or burns of more than 50% of the lower extremities and still had impaired gait dysfunction 6 months later. -aged over 18 years
* had a Functional Ambulation Category (FAC) score of 3 or higher

Exclusion Criteria:

* fourth-degree burns (involving muscles, tendons, and bone injuries)
* severe communication disorders because of intellectual impairment and psychological problems
* Patients with body types that prevent them form wearing the robot, such as a height of 4.59 feet (140cm) or 5.91 feet (185cm) or more, or severe obesity with a BMI of 35 or more.
* Patients with heart and circulatory conditions that may affect gait training.
* Patients at a high risk of falling during gait training, owing to severe dizziness and having experienced a fall within the preceeding 2 month.

Where this trial is running

Seoul

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions BurnsGait DysfunctionRobot TrainingBURNS, Gait dysfunction, Wearable robot, Robot training
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.